D. E. Shaw & Co., Inc. Baudax Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.68 - $1.87 $159,780 - $439,395	-234,971 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.58 - $8.47 $371,254 - $1.99 Million	234,971 New	234,971 $416,000

Ticker BXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,003,700
Market Cap $200K
Description
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuro...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.